Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000053417-09-000006
Filing Date
2009-01-12
Accepted
2009-01-12 16:20:33
Documents
1
Group Members
TTNP1208

Document Format Files

Seq Description Document Type Size
1 TTNP 13G/A DEC-08 ttnp1208.txt SC 13G/A 7090
  Complete submission text file 0000053417-09-000006.txt   9135
Mailing Address 466 LEXINGTON AVE NEW YORK NY 10017
Business Address 466 LEXINGTON AVE NEW YORK NY 10017 2124211000
JENNISON ASSOCIATES LLC (Filed by) CIK: 0000053417 (see all company filings)

EIN.: 132631108 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46083 | Film No.: 09521945
SIC: 2836 Biological Products, (No Diagnostic Substances)